CosmoGodino (@GodinoCosmo) header
CosmoGodino (@GodinoCosmo) profile picture

Interventional Cardiologist/Cardiologo San Raffaele/ Transcatheter interventions/Outcomes researcher/ Proud father/ As Roma fan

Ospedale San Raffaele, Milano
Joined May 2020
Photo by CosmoGodino (@GodinoCosmo)Photo by CosmoGodino (@GodinoCosmo)
Il 25 Gennaio 2025 sii terrà presso L'NH Hotel CityLife il primo SINT, meeting cardiologico che promuove il concetto di SINERGISMO tra terapia medica e procedure interventistiche. Vi aspetto instagram.com/p/DD4tq_3oY4c/…
1
49
CosmoGodino retweeted
Great work @jcecharte and @AndreaScotti21. I’m very proud of both you. Thanks for putting a spotlight on the differences in diversity regarding valvular disease. @MontefioreNYC @MontefioreNYC @EinsteinMed @crfheart
💫Check our last paper from @MonteHeart based on Race/Ethnicity disparities in severe TR @azeemlatib @AndreaScotti21 @guilbon @jtorrado_arrosa @MatteoSturlaM 🎯 Black/Hispanic ➡️advanced TR disease 🎯 A-STR ⬆️ in White ➡️ Black experienced ⬆️HF 🏥 📎 surl.li/kvqekl
6
24
3,350
Not so strange!
#AHA24: How does the benefit of microaxial flow pumps in cardiogenic shock vary by age? In a new analysis of the DanGer Shock trial, Dr. Jacob Møller & team at @CardResearchOuh find that these devices may not benefit older patients (>77 y/o) bit.ly/3Z56S3L #JACC #cvGeri #STEMI
69
New data for Spanish registry suggesting “the less residual TR, the better” after TTEER. Changing concepts ⁦@icruzgonzalez⁩ ⁦@jcecharte⁩ ⁦@PCRonline⁩ ⁦@shci_sec⁩ ⁦@MPAOSS⁩ ⁦@belcid7⁩ #TreatTR emea01.safelinks.protection.…
12
41
2,167
#TCT2024 Is it time to get rid of cause specific hospitalization as an endpoint? 2 trials showing TAVR reduces CV hosp (EARLY TAVR) and unplanned aortic hospitalization (EVOLVED) with the former hitting a primary composite driving by this cause specific endpoint.
1
15
5
67
20,230
First prospective study at Johns Hopkins on >1000 pts w/ #echofirst and #RHC data to define grades of severity of echo-based measures of RV dysfunction in PH population @CircImaging bit.ly/4f52fvV Few learning points: ❗️degree of RV dysfx -> worse outcome & symptoms ❗️echo thresholds to define mild/moderate/severe RV dysfx in PH patients based on percentiles are now available ❗️FAC, RVFWLS, and RVGLS were independently associated with outcomes, whereas TAPSE was not ❗️TAPSE remained normal except when PVR≥7 WU, and even then, was only mildly reduced (1.6±0.4 cm) ❗️RVGLS <20% in PH pts increased mortality risk ❗️TAPSE/PASP and FAC/PASP decreased with increasing PVR ❗️moderately vs mildly decreased TAPSE/PASP has a 37% increased risk of death Congratulations, @MMukherjeeMD @LunaGargani @Ivan_Echocardio @lpbadano @NAjmoneMarsan @leylaelifsade @DonalErwan @VDelgadoGarcia @CaravitaSergio @hahn_rt @robertomlang
1
35
1
80
6,821
Not every #TMVR requires contrast CT. #JACCIMG novel approach to neo-LVOT assessment by #echofirst pre-TMVR TEE: neo-LVOT area & #LVOT gradients had no significant bias compared to #YesCCT. bit.ly/3XZCQNq @hahn_rt @FabienPraz @joan_bartc
14
1
59
8,502
The #EAPCI Core Curriculum for Percutaneous Valvular & Structural Heart Intervention Published in @EuroInterventio on the occasion of #ESCCongress 2024 Significant work from the #EAPCI Training & Certification Committee and collaborators. bit.ly/3XowWGh
2
37
1
72
8,343
New insights into #LAAO post-procedural treatment. ✅ Simplified protocols for high-risk bleeding patients? ✅ Outstanding collaborative effort from several Spanish centers. @pjantunez @RodrigoEstvez1 @freixa_xavier @ignamatsant @shci_sec @scardiosal @Serlotes
This study compares simplified vs. conventional antithrombotic regimens after LAAO in high bleeding risk patients. Results suggest simplified treatment may be as effective with a lower risk of major bleeding, especially for those with prior bleeding. #Cardiology #LAAO #EAPCI @pjantunez shorturl.at/3Xdyt Editorial by @sameergafoor and @SidakpalP: shorturl.at/SNJRU
15
37
3,733
Lower plasma ferritin levels are linked to an increased risk of heart failure & diastolic dysfunction in older adults, regardless of anemia status. Iron repletion could be key in preventing heart failure. bit.ly/3uZGrAm #JACCHF #HeartFailure #ARIC #Anemia
1
80
4
197
45,935
In a large population of up to 1,000 US and European patients with intermediate- and high-risk pulmonary embolism, mechanical thrombectomy using the FlowTriever System was evaluated without a specified comparison group. The study demonstrated a favourable safety profile, with major adverse events in 1.8% of patients, and low all-cause mortality rates at 48 hours (0.3%) and 30 days (0.8%). Significant improvements were noted in haemodynamics and dyspnoea, and a majority of patients avoided overnight ICU stay post-procedure, over the course of 48 hours and 30 days following the intervention. #EIJBestOf ow.ly/kQLG50QJuET
1
13
32
5,302
The use of DOACs after TMVR, compared with VKAs, appears to reduce the risk of bleeding complications and decrease the length of hospital stay for patients, without a significant increase in the risk of thrombotic events. jacc.org/doi/10.1016/j.jacc.…
1
10
37
3,584
After mitral valve repair, women have a higher risk for all-cause mortality at lower LVESD and LVESDi and higher EF. We should consider sex-specific thresholds for LVESDi in surgical decision making in patients with severe MR. jacc.org/doi/10.1016/j.jacc.…
29
90
7,212
Optimization of valve expansion for TMVR. Degenerated 27mm Magna w sev stenosis, pre-fractured with 28mm 🎈. 29mm S3 implanted, further post-dilated on atrial side to improve expansion. No post gradient, no leak. Paced OTW. Sentinel captured calcific debries. CT neo-LVOT 321.
1
5
29
3,885
DAPAglofazin Safe in AMI pts without DM, important metabolic benefits for these patients @AHAScience #AHA23 @American_Heart Dr. Stefan James Presenting: THE WINS are in favor of DAPA
12
36
2,555
Following a pos ad board, FDA just approved renal denervation with the Recor ultrasound energy-based Paradise system. No word yet on the Medtronic radiofrequency energy-based Spyral system which received a neg ad board review. From our recent JACC editorial results looks similar.
4
9
2
30
13,921
CosmoGodino retweeted
More than 4 years ago, we performed the world's 1st EVOQUE TTVR at St. Michael's Hospital. Our patient continues to do well, paving the way for hundreds of patients suffering from tricuspid regurgitation to receive this innovative and lifesaving therapy. unityhealth.to/2023/10/evoqu…
6
1
54
4,530
The COAPT Post Approval Study is out in @JACCJournals today! Real world data on 5000 SMR patients treated with MitraClip at 406 sites showed that it was safe and effective. Free download available at this link for next 50 days: authors.elsevier.com/a/1hnDt…
2
41
2
100
23,144